A better knowledge of peptide structures interacting with major histocompatibility complex (MHC ) molecules is of great interest for better understanding of the molecular basis of immune recognition. We have isolated naturally processed peptides from a continuously growing antigenpresenting Epstein-Barr virus-transformed human B-cell line. HLA-DR complexes were purified by specific affinity chromatography and complexed peptides were released by acid treatment. The isolated peptides were separated by reversed phase chromatography and fractions were analysed by Edman degradation at picomolar ranges. From 30 fractions that were examined seven peptides bound to the HLA-DRB1*0405 and two peptides from the human leucocyte antigen (HLA) class II associated invariant chain bound to HLA-DRB1*1302. In addition, a N-terminal b-chain peptide of the 0405 allele was identified. Evaluation of amino acid sequences revealed a refined FXXL motif for the 0405 allele, in which F (phenylalanine) stands for any aromatic amino acid and L ( leucine) can be exchanged by either I (isoleucine) or V (valine). In total, three fractions contained a peptide derived from the human migration inhibition factor (MIF ), a proinflammatory cytokine that is normally produced by activated T lymphocytes and monocytes/ macrophages. Indeed, cytokine analysis revealed high amounts of MIF secreted by the B-cell line, confirming that MHC class II expressing cells can present any intrinsic peptide that contains the distinct motif for HLA-binding. For MIF, the amino acid sequence Y36IAV39 represents the required binding motif for HLA-DRB1*0405. Nevertheless, it is the first time that cytokine fragments were found to bind to HLA molecules on human B cells.
INTRODUCTION
of proteins during transport. 4 Proteolytic cleavage of the Ii in a post-Golgi compartment releases a/b dimers, making the Major histocompatibility complex (MHC ) molecules possess class II binding site susceptible for peptide binding. These the intrinsic feature to bind peptide ligands from antigens dimers are derived from internalized antigens and delivered to processed in cellular compartments. These complexes are transendosomes after being processed in lysosomes. 5, 6 The class ported to the cell surface where they present the antigenic II/peptide complex is then released to the plasma membrane fragment to the specific T cells.1 MHC class II molecules bind for recognition by specific CD4+ T cells. fragments from proteins occurring in the endosomal/lysosomal
The human MHC class II molecules are classified into compartment, including endogenous as well as phagocytosed human leucocyte antigen (HLA)-DR, DP, and DQ, depending antigens.2 The class II molecules are synthesized in the endoon the allelic form of the b-chain. Each allelic form of the plasmic reticulum and nonameric complexes are formed, conhighly polymorphic MHC molecules can bind a large array of sisting of three dimers associated with trimerized invariant different peptides to ensure T-cell mediated immunity to the chain (Ii).2,3 The a/b dimers consist of two noncovalently antigenic universe. The identification of a large number of linked 34 000 MW and 27 000 MW transmembrane chains. Ii peptides that bind to a distinct MHC molecule makes it directs this complex into the endosomal system and prevents possible to reveal the molecular prerequisites for MHC/peptide class II molecules from interacting with peptides or segments interaction. Knowledge of the structural features of MHCpresented T-cell epitopes provides attractive applications in peptide, type 2 anchors mostly reflect steric constraints.9 Life Technologies, Basel, Switzerland) supplemented as described. 8 The cell suspension was continuously stirred at Typically, type 1 anchors are amino acid residues with distinct physicochemical characteristics, reflecting the chemical 40 r.p.m. using a rotation angle of 540°. The cell density was monitored daily and the suspension was diluted 152 with fresh environment of a given pocket. On the other hand, type 2 anchors are mostly small amino acid residues that are relatively medium when a density of 1·5×106 cells/ml was reached. After 12-15 days 1·5×109 cells/l were obtained with a viability enriched, if the pocket size limits the interaction with bulky residues.10 Thus, steric constraints rather than major contri->90%. All the cells were regularly checked for Mycoplasma infection by using RIDASCREENA Mycoplasma IFA butions to the binding energy of the peptide represent the mechanism underlying their enrichment.
( Vitromex, Vilshofen, Germany). There was no contamination detectable throughout maintenance of the cell lines. Sequence analysis of pooled endogenous peptides eluted from MHC class I molecules was a successful approach to define allele-specific MHC class I binding motifs. Isolation of the HLA-DR/peptide complexes Isolation of the HLA-DR/peptide complex was performed as isolated and identified naturally processed peptides bound to HLA-DRB1*0405 (DR4) and -DRB1*1302 (DR13(6)) moldescribed by Halder et al. 16 In brief, 3×109 cells were incubated for 7 hr in 40 ml fetal calf serum (FCS)-free RPMIecules. We could define a FXXL motif for the 0405 allele, and identified a DRB1-binding peptide derived from migration 1640 medium at 37°and extensively washed with Tris-buffered saline (TBS: 50 m Tris-HCl, 0·9% NaCl, pH 7·6). The cell inhibition factor (MIF ), a cytokine, which simultaneously was secreted by the antigen-presenting B cell itself.
pellet was stored at 20°. Cells were lysed by three freeze-thaw cycles and extensive stirring on ice in a fivefold volume of lysis buffer (10 m Tris, 140 m NaCl, 0·2 mg/ml NaN 3 , 0·2 m MATERIALS AND METHODS phenylmethanesulphonyl fluoride (PMSF ), 5 m leupeptin, 10 m pepstatin, 10 m chymostatin, pH 8·0) supplemented Reagents The anti-HLA-DR monoclonal antibody (mAb) L243 (ATCC, with 2% Triton-X-100. Fragments were separated after 3 hr of lysis by centrifugation at 2000 g and the procedure was Rockville, MD) was purified from L243 hybridoma supernatant using a MAbTrapTMGII (Pharmacia LKB Biorepeated. The supernatants were centrifuged at 48 000 g and filtered through a 0·45-mm filter (Millipore Corp., Bedford, technology, Uppsala, Sweden). Zwittergent 3-12 was purchased from Calbiochem (La Jolla, CA). CNBr-activated sepharose MA). HLA-DR was isolated on a 1×2·5 cm anti-HLA-DR L243-coupled sepharose column at 4°. The use of a bovine was from Pharmacia. High pressure liquid chromatography (HPLC ) solvents (LiChrosolv gradient grade) were from serum albumin (BSA)-coupled sepharose precolumn minimized non-specific matrix binding of proteins. The following Merck (Darmstadt, Germany). All other chemicals were purchased from Fluka Chemie AG, Buchs, Switzerland at the steps were performed at 4°at a flow rate of 72 ml/min. After loading, the L243-sepharose column was washed with washing highest purity available. adjusted to a final protein concentration of 0·2-0·5 mg/ml (Bradford assay, BioRad, Hercules, CA). Normally, 3×106 DPB1*0101, and DPB1*02012, as determined by oligonucleotide hybridization after polymerase chain reaction (PCR) cells yielded 1·9-2·5 mg of HLA-DR/peptide complex. The pH was adjusted to 2·0-2·2 with trifluoracetic acid ( TFA), amplification. HLA class II peptides were isolated from the BuB1 line. Cells were cultured in 750 ml-spinner bottles and after 2 hr of incubation at 37°the peptides were separated from the DR molecule by filtering through a 30 000 MW cut-(Technomara AG, Wallisellen, Switzerland ) starting with 4×105 cells/ml in 200 ml RPMI-1640 medium (Gibco BRL, off membrane Centricon-30 (Grace Inc., Beverley, CA). The filter was washed three times with water/TFA pH 2·0 and the volume of the filtrate was reduced to 100 ml in a SpeedVac (Savant Instruments Inc., Farmingdale, NY ).
Separation of naturally processed peptides
The peptides (≤100 mg) were separated at room temperature by HPLC (pump: 140 B, Applied Biosystems, CA; detector: SPD 10 A, Shimazu Corp., Kyoto, Japan) using a flowsplitter that allowed a flow rate of 4-5 ml/min, a C 18 column (LC Packings, 300 mm×150 mm), and a linear TFA/acetonitrile gradient.16 that proline appears significantly often in the second degradation step, indicating cleavage properties of an aminopeptidase N-like enzyme. From the established peptide sequences, RESULTS the respective proteins were determined by the databases HLA expression on B cells Swissprot, PIR, and GenEMBL with programs from the Genetics Computer Group (GCG, Wisconsin Package, The amount of naturally processed peptides that yields from Madison, WI ). In 11 out of 30 fractions, a sequence filed in the cells depends mainly on the degree of HLA expression on an available database could be identified. The reliability of the the cell surface. Therefore, we first measured the HLA found sequences was controlled by comparing the amounts of expression on BuB1 and BuB cells at different cell densities by corresponding amino acids in each degradation step. Table 2 fluorescence-activated cell sorting (FACS ) analysis (Fig. 1) .
Detection of MIF
summarizes the peptide sequences and the appropriate proWe found that the HLA class II expression decreased on both teins. Two exogenous peptides derived from bovine transferrin BuB1 and BuB cells with increasing cell density. At the highest and bovine serum albumin could be identified in the analysed cell concentration (1·5×106 cells/ml ) the class II expression fractions. Both proteins are constituents of FCS contained in was #50% of the highest HLA expression measured at optimal the medium. Furthermore, seven endogenous peptides were conditions. On the other hand, this higher cell density results found, of which two were derived from the HLA class II in 150 times more cells from the same culture volume, giving invariant chain. In three fractions, a peptide derived from the finally a 75 times higher HLA yield. migration inhibition factor was identified.
Analysis of naturally processed peptides BuB1 cells secrete MIF and present MIF-derived peptides
The peptide mixtures isolated from HLA-DR were separated by HPLC. Figure 2 shows a chromatogram representative for MIF is a cytokine normally secreted by activated T lymphocytes and monocytes/macrophages however, MIF-secreting different batches. Only a few distinct peaks could be detected due to the complexity of the mixture. Most of the peaks show unstimulated B cells had not been reported so far. Because BuB1 cells presented a peptide from MIF protein, the cell shoulders or asymmetric shapes, indicating a large heterogeneity of the peptides. Fractions collected after HPLC separation cultures were tested for MIF production. After incubation of 5×105 cells for 72 hr, a final density of about 1·5×106 cells/ml were analysed using the protein sequencer ABI 476 A (Applied Biosystems) in order of their relative absorbency. In Table 1 was reached, and MIF was detected in the supernatants by solid phase sandwich ELISA. As shown in Fig. 3 , BuB1 cells the results of 30 fractions analysed are summarized. Mainly four, leucine appears to be preferred, but other hydrophobic ditions. Monocytes, freshly isolated by the MACS procedure, amino acids with a medium sized sidechain, such as isoleucine were cultured for 72 hr at a cell concentration of 1·5×106 or valine, can also be observed. Table 3 shows the sequences cells/ml. They secreted MIF in amounts of 1·8-3·5 ng/ml. from the MHCPEP database together with our results, aligned Three PLA-specific human T-cell clones from three donors according to the proposed motif for DRB1*0405. The FXXL were washed with medium at day 6 after restimulation with motif was compared with sequences from the MHCPEP antigen and further incubated for 72 hr at 1·5×106 cells/ml database expressing moderate or low affinity to DRB1*0405. in interleukin-2 (IL-2) (25 U/ml ) containing medium. Accordingly, at the relative position one, amino acids with Supernatants of these cultures contained MIF in the range of less bulky side chains show low affinity to DRB1*0405. The 2·8-7·9 ng/ml. affinity is also lower if bulky side chains are contained at the relative position four of the motif.
Identification of anchor residues
Similar motifs were found for DRB1*0101
([ YVLF ]-XX[LAIVM ] and DRB1*0401 ([ WY ]XX[ VLMA]).21,22 A Pool sequencing17 and competition assays with polyalanine
comparison of the pocket-forming amino acids in the binding substituted analogues18 allowed the definition of several motifs cleft (published at http://histo.cryst.bbk.ac.uk) demonstrated for HLA-DRB1*0405 and HLA-DRB1*1302.19 These motifs similar pockets for DRB1*0405 and DRB1*0401, but greater describe up to nine possible amino acids for each anchor differences to DRB1*0101. Pocket 1 shows no differences, in position. Therefore, we attempted to elucidate a more restricted pocket 4 the residue H 13 in DRB1*0405 changed to F in motif for these MHC types. In contrast to peptides released DRB1*0101, in pocket 6 V 11 to L, in pocket 7 D 28 and Y 30 from MHC class I molecules, class II derived peptides vary to E and C, and in pocket 9 E 9 , Y 37 , and S 57 to W, S and D, much more in size, with a length ranging from 13 to 25 amino respectively. In DRB1*0401 only S 57 and R 71 are exchanged acids.13 The detection limit of the sequencer used enabled the by D and K. This further suggests that the anchor residue one determination of 13-18 amino acid residues for each peptide is of type 1, because its sidechain is bulky and does not fit analysed. Moreover, only N-terminal sequences of isolated exactly in a pocket formed by the b-chain of the HLA peptides that are not necessarily part of the binding cleft may have been found. Therefore, we extended in a first step the molecule. On the other hand, the anchor residue at position teins. Isolation of naturally processed antigens normally yields a complex mixture of various peptides. At least 654 different peptides were detected from the murine class II molecule IAd,23 which only account for about 10% of the class II molecules. This relatively low recovery can be explained either by a loss of peptides during isolation, the presence of undetectable peptides, or 'empty' MHC molecules. In any case, high sensitive analytic tools like capillary HPLC combined with either high sensitive Edman degradation or nano-spray mass spectrometry are needed to identify naturally processed peptides. Nevertheless, the most important peptides are probably selected by this approach. Of class II ligands, both the N-and C-termini are ragged and hang out of the binding groove, and are thought to be It has been suggested that T-cell recognition of presented peptides is independent of peptide affinity to the MHC mol-DISCUSSION ecule.28 Furthermore, it was shown29 that peptides are still able to bind to HLA molecules even after substitution of We have isolated naturally processed peptides from the EBVanchor residues with amino acids having contrary physicotransformed human B-cell line BuB1 and determined the amino acid sequence of 11 different peptides from nine prochemical properties. A higher affinity could be obtained in Table 3 . Known HLA-DRB1*0405 binding peptides, aligned for a possible motif
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